FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nivaquine 68mg/5ml syrup (Beacon Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Genesis Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minocycline 10mg dental gel VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
High purity factor VIII fraction 250iu powder and solvent for injection solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Haemoctin 250unit powder and solvent for solution for injection vials (Biotest (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Minocycline 2% dental gel sugar free 5 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
High Purity Factor VIII 250unit powder and solvent for solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Monoclate-P 250unit powder and solvent for solution for injection vials (Aventis Behring Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Beriate P 250unit powder and solvent for solution for injection vials (Aventis Behring Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dentomycin 2% dental gel (Blackwell Anaesthetics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beriate P 250unit powder and solvent for solution for injection vials (Aventis Behring Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Haemoctin 250unit powder and solvent for solution for injection vials (Biotest (UK) Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Monoclate-P 250unit powder and solvent for solution for injection vials (Aventis Behring Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dentomycin 2% dental gel (Blackwell Anaesthetics Ltd) 5 dose 5 x 0.5g doses VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 500mg tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Valupak Vegetarian Glucosamine hydrochloride 500mg tablets (BR Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pro Coxam 500mg tablets (Synergy Biologics Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 500mg tablets 30 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pro Coxam 500mg tablets (Synergy Biologics Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Valupak Vegetarian Glucosamine hydrochloride 500mg tablets (BR Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags 15 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (A A H Pharmaceuticals Ltd) 15 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Sigma Pharmaceuticals Plc) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyridoxine 100mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Premier Vitamin B6 100mg tablets (Premier Health) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
HealthAid Vitamin B6 100mg tablets (HealthAid Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyridoxine 100mg tablets 90 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (A A H Pharmaceuticals Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Special Order) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Unichem Plc) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Premier Vitamin B6 100mg tablets (Premier Health) 90 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 100mg implant (Organon Pharma (UK) Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
HealthAid Vitamin B6 100mg tablets (HealthAid Ltd) 90 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salbutamol 1mg/ml / Ipratropium bromide 200micrograms/ml nebuliser liquid 2.5ml ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salbutamol 1mg/ml / Ipratropium bromide 200micrograms/ml nebuliser liquid 2.5ml ampoules 60 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Arrow Generics Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) 60 ampoule 6 x 10 ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Arrow Generics Ltd) 60 ampoule 6 x 10 ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid ampoules (A A H Pharmaceuticals Ltd) 60 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Aprotinin 500,000 Kallikrein inactivator units/50ml solution for infusion vials (Nordic Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aprotinin 500,000 Kallikrein inactivator units/50ml solution for infusion vials (Nordic Pharma Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Xerostom dry mouth spray sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xerostom dry mouth spray (Curaprox (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Xerostom dry mouth spray sugar free 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Xerostom dry mouth spray sugar free 6.25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xerostom dry mouth spray (Curaprox (UK) Ltd) 6.25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xerostom dry mouth spray (Curaprox (UK) Ltd) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (A A H Pharmaceuticals Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft polymer wound contact dressing impregnated with silver 10cm x 12cm 25 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul SSD dressing 10cm x 12cm (Urgo Ltd) 25 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (medac UK) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (medac UK) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 5cm x 7.5cm (Richardson Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 7.5cm x 10cm (Richardson Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 20cm x 30cm (Richardson Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 5cm x 7.5cm (Richardson Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 5cm x 7.5cm (Richardson Healthcare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 7.5cm x 10cm (Richardson Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 7.5cm x 10cm (Richardson Healthcare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 20cm x 30cm (Richardson Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SilTact dressing 20cm x 30cm (Richardson Healthcare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
L-Arginine 500mg capsules (G & G Food Supplies Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) 100 ml (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsacrine 75mg/1.5ml solution for infusion ampoules and diluent VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml solution for infusion bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for injection vials and diluent (Goldshield Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml solution for infusion bottles 5 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amsacrine 75mg/1.5ml solution for injection ampoules and diluent 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml solution for infusion bottles (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for infusion ampoules and diluent (NordMedica A/S) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for injection vials and diluent (Goldshield Healthcare Ltd) 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for infusion ampoules and diluent (NordMedica A/S) 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml solution for infusion bottles (Kent Pharma (UK) Ltd) 5 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucosamine sulphate 1.5g oral powder sachets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desmopressin 25microgram oral lyophilisates sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desmopressin 50microgram oral lyophilisates sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desmopressin 50microgram oral lyophilisates sugar free 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noqdirna 25microgram oral lyophilisates (Ferring Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glusartel 1500mg oral powder sachets (HFA Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desmopressin 25microgram oral lyophilisates sugar free 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine sulphate 1.5g oral powder sachets sugar free 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine sulfate 1.5g oral powder sachets sugar free (Crescent Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noqdirna 50microgram oral lyophilisates (Ferring Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glusartel 1500mg oral powder sachets (HFA Healthcare Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine sulfate 1.5g oral powder sachets sugar free (Crescent Pharma Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noqdirna 50microgram oral lyophilisates (Ferring Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 70 of 86 Next End

This concept is not in any reference sets

Back to Start